Advisory Services Network, LLC Takeda Pharmaceutical CO LTD Transaction History

Advisory Services Network, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$13.36 - $15.43 $78,316 - $90,450	5,862 New	5,862 $83,000
Q1 2023 May 17, 2023	BUY	$15.28 - $16.48 $687 - $741	45 Added 0.63%	7,205 $118,000
Q4 2022 Feb 13, 2023	BUY	$12.42 - $15.62 $88,927 - $111,839	7,160 New	7,160 $111,000
Q3 2021 Nov 05, 2021	SELL	$16.3 - $17.26 $23,912 - $25,320	-1,467 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$16.55 - $18.64 $24,278 - $27,344	1,467 New	1,467 $25,000
Q1 2021 May 24, 2021	SELL	$16.71 - $19.9 $76,030 - $90,545	-4,550 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$15.39 - $18.97 $7,233 - $8,915	470 Added 11.52%	4,550 $83,000
Q3 2020 Nov 16, 2020	BUY	$17.1 - $19.19 $69,768 - $78,295	4,080 New	4,080 $73,000
Q2 2020 Aug 10, 2020	SELL	$14.59 - $19.5 $29,282 - $39,136	-2,007 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $11,718 - $18,279	-900 Reduced 30.96%	2,007 $30,000
Q4 2019 Feb 04, 2020	BUY	$16.88 - $20.83 $14,027 - $17,309	831 Added 40.03%	2,907 $57,000
Q2 2019 Aug 01, 2019	BUY	$16.58 - $20.49 $17,342 - $21,432	1,046 Added 101.55%	2,076 $0
Q1 2019 May 20, 2019	BUY	$16.7 - $21.52 $17,201 - $22,165	1,030 New	1,030 $21,000

318

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.